Med Sci (Paris)
Volume 30, Number 8-9, Août–Septembre 2014
|Page(s)||809 - 811|
|Published online||01 September 2014|
De l’exome à l’avatar : vers une « oncologie de précision » ?
From exome sequencing to avatar creation: towards « precision oncology »?
UMR 7268 ADÉS, Aix-Marseille Université/EFS/CNRS, Espace éthique méditerranéen, Hôpital d’adultes La Timone, 264, rue Saint-Pierre, 13385 Marseille Cedex 05, France
2 CoReBio PACA, case 901, parc scientifique de Luminy, 13288 Marseille Cedex 09, France
According to recent reports, the success rate of targeted therapy directed by “actionable mutations” found in tumour DNA is rather low (10 to 20%). Interesting attempts have been made to improve this by establishing mouse “avatars” and testing drugs on them. The first results are promising, but the clinical utility of this expensive and cumbersome approach needs to be ascertained by more extensive testing.
© 2014 médecine/sciences – Inserm
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.